Cognitive changes after bariatric surgery using VR Neurotracker and Neuropsi testing
Effect of Bariatric Surgery on Cognitive Performance Assessed Using a Virtual Reality Program and the Neuropsi Battery.
NA · Hospital General de México Dr. Eduardo Liceaga · NCT07229924
This study will test whether bariatric surgery combined with virtual‑reality Neurotracker sessions improves thinking and memory in adults with morbid obesity scheduled for surgery.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 42 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Hospital General de México Dr. Eduardo Liceaga (other gov) |
| Locations | 2 sites (Montreal, Quebec and 1 other locations) |
| Trial ID | NCT07229924 on ClinicalTrials.gov |
What this trial studies
This prospective quasi-experimental study enrolls adults with morbid obesity who are candidates for bariatric surgery. Cognitive performance is measured using the Neurotracker virtual‑reality tool and the Neuropsi neuropsychological battery. Participants complete Neurotracker sessions three times per week for two weeks before surgery and repeat testing at postoperative follow-up visits, including at about 3 months. The study compares pre- and post-surgery cognitive performance to identify changes associated with surgical weight loss and reduced systemic inflammation.
Who should consider this trial
Good fit: Adults aged 18–65 with morbid obesity (BMI >40, or BMI >35 with obesity-related comorbidities) who meet bariatric surgery criteria and have no visual impairment or history of cerebrovascular events are ideal candidates.
Not a fit: Patients younger than 18 or older than 65, those with visual impairment, prior stroke/CVE, or active drug addiction are excluded and unlikely to benefit from the intervention.
Why it matters
Potential benefit: If successful, the approach could improve attention and memory after bariatric surgery and help identify patients who gain the most cognitive benefit.
How similar studies have performed: Prior studies have reported cognitive improvements after bariatric surgery and benefits from cognitive training in other groups, but combining VR Neurotracker training with Neuropsi testing in this population is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: A. Age (18-65 years) B. Diagnostic of morbid obesity with a body mass index (BMI) \> 40 kg/m2, or, C. Obesity grade II (BMI \> 35 kg/m2) and associated comorbidities (Diabetes Mellitus type 2, Hypertension, Ischemic Cardiopathy, Hyperlipidemia, Hepatic Steatosis, Metabolic Syndrome, Obstructive Sleep Apnea, Pickwick Syndrome) D. Bariatric surgery criteria. Exclusion Criteria: A. Age \< 18 years, \> 65 years B. Visual impairment C. Personal history of CVE D. Drug addiction.
Where this trial is running
Montreal, Quebec and 1 other locations
- Faubert Lab — Montreal, Quebec, Canada (WITHDRAWN)
- Hospital General de México "Dr. Eduardo Licega" — Mexico City, Mexico City, Mexico (RECRUITING)
Study contacts
- Principal investigator: Argelia Pérez Pacheco, PhD — Hospital General de México Dr. Eduardo Liceaga
- Study coordinator: Argelia Pérez Pacheco, PhD
- Email: argeliapp@ciencias.unam.mx
- Phone: +525527892000
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Obesity, Obesity and Obesity-related Medical Conditions, Bariatric Surgery, Cognition, NeuroTracker, Neuropsi